| Original language | English (US) |
|---|---|
| Pages (from-to) | 951-954 |
| Number of pages | 4 |
| Journal | Journal of Investigative Dermatology |
| Volume | 137 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2017 |
Fingerprint
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Dermatology
- Cell Biology
Cite this
}
Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib. / King, Brett; Lee, Alfred Ian; Choi, Jaehyuk.
In: Journal of Investigative Dermatology, Vol. 137, No. 4, 01.04.2017, p. 951-954.Research output: Contribution to journal › Article
TY - JOUR
T1 - Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib
AU - King, Brett
AU - Lee, Alfred Ian
AU - Choi, Jaehyuk
PY - 2017/4/1
Y1 - 2017/4/1
UR - http://www.scopus.com/inward/record.url?scp=85015956860&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85015956860&partnerID=8YFLogxK
U2 - 10.1016/j.jid.2016.10.044
DO - 10.1016/j.jid.2016.10.044
M3 - Article
C2 - 27887955
AN - SCOPUS:85015956860
VL - 137
SP - 951
EP - 954
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
SN - 0022-202X
IS - 4
ER -